Bicara Therapeutics (BCAX) Shares Outstanding (2023 - 2026)

Bicara Therapeutics has reported Shares Outstanding for 4 years, with the latest figure at $65.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 20.21% year-over-year to $65.5 million; the trailing twelve-month figure through Mar 2026 stood at $65.5 million (up 20.21% YoY), and the FY2025 full-year result was $56.6 million, up 3.97% from the prior year.
• Shares Outstanding for Q1 2026 stood at $65.5 million, up from $56.6 million in the prior quarter.
• The five-year high for Shares Outstanding was $65.5 million in Q1 2026, with the low at $579975.0 in Q3 2023.
• Historically, Shares Outstanding has averaged $36.1 million across 4 years, with a median of $54.4 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding jumped 9281.39% — and 2025, when it increased 0.37%.
• Bicara Therapeutics' Shares Outstanding stood at $640386.0 in 2023, then soared by 8401.12% to $54.4 million in 2024, then climbed by 3.97% to $56.6 million in 2025, then rose by 15.81% to $65.5 million in 2026.
• The last three Shares Outstanding figures came in at $65.5 million (Q1 2026), $56.6 million (Q4 2025), and $54.6 million (Q3 2025), per Business Quant data.